News | Cardiovascular Surgery | May 04, 2016

First Central Pennsylvania Patients Receive New Aortic Valve Reconstruction Procedures

Patients' own heart tissue used to reconstruct aortic valve

aortic valve reconstruction, surgery, PinnacleHealth, Pennsylvania

May 4, 2016 — Three PinnacleHealth patients recently underwent a new procedure for aortic valve reconstruction using the patients' own heart tissue (pericardium) to create the new valves. It was first available in central Pennsylvania at PinnacleHealth and is currently performed at a handful of institutions across the country.

Aortic valve reconstruction patients benefit from using their own pericardial tissue as it has fewer tendencies to scar and calcify, which is the main reason for failure of tissue valves obtained from animals. The body also is less likely to mount an immune response against the patient's own tissue. In addition, these patients do not need lifelong blood thinners, which are required when mechanical aortic valves are used.

"Aortic valve reconstruction represents yet another advancement at PinnacleHealth's CardioVascular Institute and our commitment to lead the way for the benefit of our patients," said Mubashir Mumtaz, M.D., FACS, FACC, chief of cardiothoracic surgery and surgical director of the structural heart program at PinnacleHealth. "Using one's own tissue has numerous benefits for the patient. The reconstructed valves are functioning well in all three patients three months post-surgery."

Mumtaz travelled to Japan to gain insights from the world-renowned team of Prof. Shigeyuki Ozaki in Tokyo, who has developed the procedure and published results in more than 400 hundred patients.

The purpose of aortic valve reconstruction is to repair the patient's own aortic valve in such a way as to restore it to its full function. Normally, the aortic valve has three flaps, or leaflets, that regulate blood flow by opening and closing, allowing blood to flow through the body. For those with aortic valve disease where the leaflets have abnormal function, the decision to repair or replace the valve is a complex decision.

For more information:

Related Content

Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems| September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery| September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | September 11, 2017
September 11, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has sele
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery| September 08, 2017
September 8, 2017 — ClearFlow Inc.
LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

Feature | Left Atrial Appendage (LAA) Occluders| September 07, 2017
September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices| September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial
News | Heart Valve Technology| September 05, 2017
Minneapolis Heart Institute Foundation announced it has enrolled the first-in-the-world patient in a clinical study to...
World's First Successful 52-mm Transcatheter Tricuspid Valve Implantation Completed in Italy
News | Heart Valve Technology| August 31, 2017
NaviGate Cardiac Structures Inc. (NCSI) announced that its Gate catheter-guided tricuspid atrioventricular valved stent...
Overlay Init